Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Morabito C et al. | 2010 | intact cell/cell culture, C2C12 cells (undifferentiated myoblasts and differentiated myotubes) | magnetic field, low frequency, 50/60 Hz | 0.1–1 mT |
Morabito C et al. | 2010 | intact cell/cell culture, PC-12 cells | magnetic field, low frequency, 50/60 Hz | 0.1–1 mT |
Hwang YH et al. | 2011 | intact cell/cell culture, RBL-2H3 (rat basophilic leukemia cells) | magnetic field, low frequency, 50/60 Hz | 0.1–1 mT |
Zhang J et al. | 2016 | bacterium, <i>alpha-hemolytic Streptococcus</i> H1S-33 | magnetic field, 50/60 Hz | 0.1–1.5 mT |
Nindl G et al. | 1997 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, signals/pulses, 50/60 Hz | 0.1–1.8 mT |
Masoudian N et al. | 2015 | organelle/cell part, synaptosomes | magnetic field, 50/60 Hz | 0.1–2 mT |
Khadir R et al. | 1999 | intact cell/cell culture, neutrophils (from human venous blood) | magnetic field, 50/60 Hz, co-exposure | 0.1–44 mT |
Potenza L et al. | 2012 | intact cell/cell culture, truffle mycelium <i>Tuber borchii</i> | magnetic field, static magnetic field, 50/60 Hz, DC | 0.1–300 mT |
Ikeda K et al. | 2003 | intact cell/cell culture, human peripheral blood mononuclear cells | magnetic field, 50/60 Hz, power transmission line | 100 µT–485 mT |
Marchionni I et al. | 2006 | intact cell/cell culture | RF field, 50/60 Hz, magnetic field | 125 µT |
Goodman EM et al. | 1976 | intact cell/cell culture, slime mold microplasmodia (<i>Physarum polycephalum</i>, line M<sub>3</sub>C VI) | electric field, magnetic field, low frequency, 50/60 Hz | 200 µT |
Ali FM et al. | 2003 | animal, rat/albino, whole body | magnetic field, 50/60 Hz | 200 µT |
Revoltella RP et al. | 1993 | intact cell/cell culture, Friend erythroleukemia cell line (line 3BM-78, clone H19 from line 5-86, line 707M, clone F4-1 from line F4-N) | magnetic field, 50/60 Hz | 200 µT |
Gao M et al. | 2011 | intact cell/cell culture, <i>Aspergillus niger</i> | magnetic field, low frequency, 50/60 Hz | 0.2–1 mT |
Petrini C et al. | 1997 | intact cell/cell culture, human peripheral blood mononuclear cells | magnetic field, 50/60 Hz, co-exposure | 0.2–2 mT |
Moghadam MK et al. | 2011 | intact cell/cell culture, neuron units | magnetic field, low frequency, 50/60 Hz | 207.2 µT |
Blumenthal NC et al. | 1997 | intact cell/cell culture, rat tendon fibroblasts and rat bone marrow osteoprogenitor cells (Sprague-Dawley rat) | magnetic field, static magnetic field, intermediate frequency, 50/60 Hz | 0.25–0.5 mT |
Lee YJ et al. | 2016 | intact cell/cell culture, CD4<sup>+</sup> T cells derived from mice (C57/BL6 mice and Foxp3-GFP mice) | magnetic field, 50/60 Hz | 0.3 mT |
Denaro V et al. | 2011 | intact cell/cell culture | low frequency, signals/pulses, 50/60 Hz, magnetic field | 0.4 mT |
Wu X et al. | 2014 | intact cell/cell culture, FL cells (human amniotic cells) | magnetic field, 50/60 Hz | 0.4 mT |
He YL et al. | 2013 | intact cell/cell culture, granule cells | magnetic field, 50/60 Hz | 0.4–1 mT |
Percherancier Y et al. | 2015 | intact cell/cell culture, NIH3T3 cells (mouse fibroblasts) | magnetic field, 50/60 Hz | 0.4–1 mT |
Davies E et al. | 2000 | intact cell/cell culture, slime mold <i>Dictyostelium discoideum</i> | magnetic field, signals/pulses, 50/60 Hz, low frequency, therapeutic/medical device | 0.4–3 mT |
Salerno S et al. | 2009 | intact cell/cell culture, human t-lymphocytes | magnetic field, static magnetic field, 50/60 Hz, DC | 0.5 mT |
Yamaguchi DT et al. | 2002 | intact cell/cell culture, ROS 17/2.8 (osteoblast-like cells) and MC3T3-E1 cells (mouse osteoblast-like cells) | magnetic field, low frequency, 50/60 Hz, therapeutic/medical device | 0.6–1.25 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.